In fact, high-profile examples of payers pulling back on coverage are stacking up: North Carolinas state health plan dropped GLP-1s after spending $100 million, Ascension eliminated all weight-loss drug coverage, and Mayo Clinic capped lifetime GLP-1 benefits at $20,000
The names refer to the same underlying peptide sequence
d , Lysates from HEK293T cells transfected with Flag-tagged NMHC-IIA Coiled coil (CC) domain (IIA-CC-Flag) and HA-tagged N and C terminal fragments of TMEFF1 were subjected to IP with anti-HA, and immunoblotted as indicated
In clinical practice, individualized drug regimens need to be developed based on patient-specific conditions, and therapeutic drug monitoring and individualized genetic testing are effective tools to increase the efficacy and decrease the adverse effects of metformin for PCOS therapy
In this challenging landscape, GLP-1s could be a formidable addition to treatment providers' toolkits